Sarah Buhr

Write about the wild new frontier of biotechnology (3D printed organs, one drop blood tests, or hamburgers grown in a lab? I’m your gal), also a bit of politics, gender and diversity and sometimes they put me on camera at TechCrunch to tell you about cool new gadgets and gizmos.

Crunchbase profile →

Featured Picks from Sarah Buhr


Latest from Sarah Buhr

  • Tech employees protest in front of Palantir HQ over fears it will build Trump’s Muslim registry

    Tech employees protest in front of Palantir HQ over fears it will build Trump’s Muslim registry

    Silicon Valley is no stranger to protests against tech companies. But it’s unusual when the tech workers themselves protest tech. Such was the case this morning in front of Palantir headquarters in Palo Alto where 50 people in the tech community came out in the pouring rain to demand the data mining startup take a firm stand against the makings of a Muslim registry. The organizers… Read More

  • Hyperloop Transportation Technologies plans to connect all of Europe, starting with the Czech Republic

    Hyperloop Transportation Technologies plans to connect all of Europe, starting with the Czech Republic

    Hyperloop Transportation Technologies (HTT) may be a step behind its rival Hyperloop One but is making its own plans to go global — starting with an announcement today HTT has signed an agreement to explore connecting a hyperloop system from Slovakia to the Czech Republic. HTT already has an agreement with the city of Bratislava, Slovakia to build a hyperloop there, but this new… Read More

  • Lumo opens up its backend technology to third-party providers

    Lumo opens up its backend technology to third-party providers

    As the fitness wearables market continues to climb, Lumo Bodytech, a startup making wearables focused on things like running and posture, has decided to further business revenue by licensing its platform. Lumo, valued at $41 million according to Pitchbook, now plans to open up its proprietary tech stack — including software, algorithms, applications, and hardware — to third… Read More

  • Fabletics launches a free Daily Burn-like workout and other perks for members

    Fabletics launches a free Daily Burn-like workout and other perks for members

    Fabletics, the workout clothing startup co-founded by Oscar-nominated mega star Kate Hudson, is launching an online workout platform for those who adhere to that fit and fabulous lifestyle. The online workouts are part of Fabletics’ extended community perks and will consist of new, high-profile workout partners each month from top studios such as Physique 57, Body by Simone and The… Read More

  • Forward, a $149 per month medical startup, aims to be the Apple Store of doctor’s offices

    Forward, a $149 per month medical startup, aims to be the Apple Store of doctor’s offices

    It was cold and pouring outside as the Uber pulled up at 180 Sutter Street in downtown San Francisco. Inside, a man dressed all in black offered to take my jacket and umbrella as he ushered me through the clinical white lobby to a set of chairs, handing me a bottle of VOSS. I scanned the room, eyeing a bunch of connected fitness tools and fancy skin serums on a glass table in the front… Read More

  • Bio
    A new lawsuit alleges anti-aging startup Elysium Health hasn’t paid its sole supplier

    A new lawsuit alleges anti-aging startup Elysium Health hasn’t paid its sole supplier

    Chromadex, the sole supplier of anti-aging startup Elysium Health‘s two main product ingredients pterostilbene and Nicotinamide Riboside (NR), is suing the startup for failure to make payments on those ingredients and for breach of a trademark and royalties agreement. According to a document on Chromadex’s website, dated December 29, 2016, Elysium “made… Read More

  • Bio
    Arizona plans to sue Theranos over faulty blood tests

    Arizona plans to sue Theranos over faulty blood tests

    Arizona Attorney General Mark Brnovich is soliciting outside legal counsel to pursue a consumer fraud lawsuit against the beleaguered blood testing startup Theranos, according to a document posted on the state’s procurement website. Brnovich has so far declined to comment on any action, but the document contends Theranos may have defrauded customers in the state and the office is… Read More

  • Bio
    Women’s health startup Celmatix now offers genetic testing for fertility issues

    Women’s health startup Celmatix now offers genetic testing for fertility issues

    Celmatix, a startup with a focus on personalized medicine for women, wants to take some of the mystery out of the science of baby-making with a new type of DNA-based fertility test called Fertilome. Fertilome looks at 49 variants in 32 genes that give you a likelihood or not for inherited disorders such as endometriosis or PCOS to help women determine the best course of action to take based… Read More

  • Bio
    Illumina wants to sequence your whole genome for $100

    Illumina wants to sequence your whole genome for $100

    The first sequencing of the whole human genome in 2003 cost roughly $2.7 billion, but DNA sequencing giant Illumina has now unveiled a new machine that the company says is “expected one day” to order up your whole genome for less than $100. Illumina’s CEO Francis deSouza showed off the machine, called the NovaSeq, onstage at the JP Morgan Healthcare Conference in downtown… Read More

  • Remedy is a Khosla-backed teledoc with A.I. capabilities for the uninsured

    Remedy is a Khosla-backed teledoc with A.I. capabilities for the uninsured

    There are quite a few telemedicine startups to choose from these days including Doctor on Demand, HealthTap and even some of the older, more established companies like MDLive or American Well but Remedy is a new one we’ve just been turned onto promising high-quality doctors at a lower cost per visit with the use of what it refers to as artificial intelligence to help diagnose what… Read More

  • Mall cop robot startup Knightscope is launching a “mini-IPO”

    Mall cop robot startup Knightscope is launching a “mini-IPO”

    Knightscope, the Dalek-like mall security robot startup we’ve mentioned here before has decided to do one of those new crowdsourced “mini-IPOs.” Also referred to as Regulation A+, these types of public offerings for private companies just became legal about a year ago to give startups access to capital from just about anyone. They are basically crowdfunding with… Read More

  • Bio
    Theranos slashes another 41 percent of its workforce

    Theranos slashes another 41 percent of its workforce

    Not a week goes by and it seems like we hear more bad news about Silicon Valley’s darling turned cautionary tale Theranos. The latest bit is a whopping 155 layoffs at the company today. The one drop blood test company once worth $9 billion took a quite the tumble from grace after an intense series of investigations from the Centers for Medicare & Medicaid Services and the U.S. Food… Read More

  • Hyperloop One’s Global Challenge could help speed government connections as it preps for its test in the desert

    Hyperloop One’s Global Challenge could help speed government connections as it preps for its test in the desert

    After sifting through thousands of applications since May of 2015, Hyperloop One announced today it has whittled its competitors in its Global Challenge down to 35 semifinalist teams from all over the world. According to H1, these teams come from 17 countries and represent every continent but Antarctica — 11 teams hail from the U.S., 5 from India and 4 are in the U.K. The company has… Read More

  • Bio
    Grail is raising at least $1 billion to fund its early cancer screening test

    Grail is raising at least $1 billion to fund its early cancer screening test

    The early cancer screening startup Grail plans to raise more than $1 billion in Series B financing, possibly up to $1.8 billion. While the company doesn’t want to name investor names, only mentioning in a release the funding will come “primarily from undisclosed private and strategic investors,” Microsoft co-founder Bill Gates, Amazon founder Jeff Bezos, Google Ventures… Read More

  • Bio
    Silicon Valley Bank predicts a 2017 cure for the healthtech investment doldrums

    Silicon Valley Bank predicts a 2017 cure for the healthtech investment doldrums

    Things are looking up for biotech and health device startups wanting to cash in on VC dollars or go public this year. According to Silicon Valley Bank’s latest report on healthcare investments and exits, a conservative 2016 has set up 2017 for a hearty boom. Though biopharma M&A activity declined slightly last year and IPOs declined more than 30 percent, according to the report… Read More

  • An Amazon Echo may be the key to solving a murder case

    An Amazon Echo may be the key to solving a murder case

    Internet-connected devices may start helping in criminal cases. As first reported in The Information, police in Bentonville, Arkansas have issued a warrant to Amazon, asking the company to hand over data from an Echo device to help prosecute a suspected murderer. James Andrew Bates, the suspect in the case, was charged with first-degree murder in November of 2015 after authorities… Read More

  • Bio
    Move over Cas9, CRISPR-Cas3 might hold the key to solving the antibiotics crisis

    Move over Cas9, CRISPR-Cas3 might hold the key to solving the antibiotics crisis

    Researchers at North Carolina-based Locus Biosciences think they have a potential cure for antibiotic resistance using CRISPR’s lesser-known Cas3 enzyme. Most of the interest in CRISPR technology centers around the enzyme Cas9, which acts as a type of genetic scissors, allowing scientists to snip out, edit and replace DNA at certain intervals along the genome. However, Cas3 goes beyond… Read More

  • The top biotech stories of 2016

    The top biotech stories of 2016

    Biotech has been very hot this year as one of the fastest growing tech sectors as costs have plummeted, allowing innovation to speed up and bring us exciting innovations in health. But it’s been a bit of a rollercoaster ride for investors. The many Theranos scandals became a primer on what not to do when building a billion-dollar biotech startup and then we had exciting IPOs (and a… Read More

  • Eaze CEO steps down

    Eaze CEO steps down

    Keith McCarty, founder of the well-funded pot delivery startup Eaze, is stepping down from his position as CEO. Instead, the startup’s chief product and technology officer Jim Patterson will take on the role and McCarty will remain on the board of directors “as a strategic advisor on company growth,” says a blog post on the site announcing the change of roles. McCarty… Read More

  • 10 high-tech holiday gifts for your furry friends

    Welcome to the 2016 TechCrunch Holiday Gift Guide! We’ll be rolling out a bunch of guides leading up to Christmas, hopefully making your holiday shopping a little easier. Looking for gifts for others on your list? Check out our full 2016 Gift Guide Hub. Have a furry friend and want to spoil them with tech treats? This is the list for you! From cat cams to apps to occupy them while you… Read More